Submit Deal

ASTRAZENECA PLC

HQ - Cambridge

Summary

AstraZeneca is a research-based bio-pharmaceutical company specializing in innovative research and development (R&D) therapies, including oncology, bioPharmaceuticals, cardiovascular, renal, and immunology.

Deals Overview

Total Deals32

Valued Deals29

Total Value£ 51.27 B

Avg. Deal Size£ 1.77 B

Market Context

Subsidiaries

ALEXION PHARMACEUTICALS INC

7 transactions

Senior Management

Marc Dunoyer
Chief Executive Officer
Aradhana Sarin
CFO
Anas Younes
Senior Vice President

Sort

06 Nov 2015|United States|Pharmaceuticals

Target: ZS PHARMA INC

Bidder: ASTRAZENECA PLC

4 Service Providers

2 Target | 2 Bidder

6 Dealmakers

3 Target | 3 Bidder

£ 1.76 B

Value

02 Aug 2017|United Kingdom|Pharmaceuticals

Target: ASTRAZENECA PLC AND MERCK & CO. INC. JOINT VENTURE

Bidder: ASTRAZENECA PLC

1 Service Providers

1 Bidder

1 Dealmakers

1 Bidder

n/a

Value

24 Jul 2018|United Kingdom|Pharmaceuticals

Target: ASTRAZENECA PLC (ATACAND & ATACAND PLUS)

Bidder: CHEPLAPHARM ARZNEIMITTEL GBMH

£ 159 M

Value

26 Sep 2018|United States|Biotechnology

Target: SYNTIMMUNE INC

Bidder: ALEXION PHARMACEUTICALS INC

6 Service Providers

2 Target | 2 Bidder | 2 Vendor

22 Dealmakers

3 Target | 13 Bidder | 6 Vendor

£ 1.07 B

Value

28 Mar 2019|Japan|Pharmaceuticals

Target: DAIICHI SANKYO (TRASTUZUMAB DERUXTECAN)

Bidder: ASTRAZENECA PLC

3 Service Providers

2 Bidder | 1 Vendor

11 Dealmakers

5 Bidder | 6 Vendor

£ 5.26 B

Value

16 Oct 2019|United States|Biotechnology

Target: ACHILLION PHARMACEUTICALS

Bidder: ALEXION PHARMACEUTICALS INC

6 Service Providers

4 Target | 2 Bidder

21 Dealmakers

17 Target | 4 Bidder

£ 732 M

Value

05 May 2020|United States|Biotechnology

Target: PORTOLA PHARMACEUTICALS

Bidder: ALEXION PHARMACEUTICALS INC

7 Service Providers

4 Target | 3 Bidder

50 Dealmakers

29 Target | 21 Bidder

£ 1.31 B

Value

12 Dec 2020|United States|Biotechnology

Target: ALEXION PHARMACEUTICALS INC

Bidder: ASTRAZENECA PLC

20 Service Providers

6 Target | 14 Bidder

63 Dealmakers

37 Target | 26 Bidder

£ 29.44 B

Value

01 Dec 2020|United Kingdom|Pharmaceuticals

Target: CRESTOR

Bidder: GRUNENTHAL

3 Service Providers

2 Bidder | 1 Vendor

12 Dealmakers

10 Bidder | 2 Vendor

£ 262 M

Value

29 Sep 2021|United States|Biotechnology

Target: CAELUM BIOSCIENCES

Bidder: ASTRAZENECA PLC

6 Service Providers

2 Target | 2 Bidder | 2 Vendor

10 Dealmakers

4 Target | 3 Bidder | 3 Vendor

£ 257 M

Value

01 Nov 2021|United Kingdom|Pharmaceuticals

Target: ASTRAZENECA PLC (EKLIRA AND DUAKLIR)

Bidder: COVIS PHARMA

7 Service Providers

6 Bidder | 1 Vendor

13 Dealmakers

9 Bidder | 4 Vendor

£ 197 M

Value

06 Dec 2021|United Kingdom|Biotechnology

Target: BENEVOLENTAI

Bidder: TEMASEK HOLDINGS LIMITED

20 Service Providers

6 Target | 14 Bidder

71 Dealmakers

40 Target | 31 Bidder

£ 1.28 B

Value